Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dichotomies in <i>Ex Vivo</i> and <i>In Vivo</i> Performance of Receptor-Binding Mutants of Adeno-Associated Virus Vectors.

Human gene therapy·2026
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

Trans-dimerization of Amyloid Precursor Protein family members induces pre- and postsynaptic differentiation through distinct signaling pathways.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same author

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Molecular therapy. Advances·2026
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026

Related Experiment Video

Updated: Jan 8, 2026

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

2.5K

Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery.

Christian J Buchholz1, Thorsten Friedel2, Hildegard Büning3

  • 1Paul-Ehrlich-Institut, 63225 Langen, Germany; German Cancer Consortium, 69120 Heidelberg, Germany.

Trends in Biotechnology
|October 27, 2015
PubMed
Summary

Gene transfer technology now precisely targets specific cells using engineered viral vectors. This advance in targeted gene delivery opens new avenues for gene function studies and molecular medicine applications.

Keywords:
AAV vectorcell entry receptordirected evolutionlentiviral vectorrational designsurface display

More Related Videos

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.8K
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

16.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

2.5K
Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.8K
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

16.1K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene transfer technology has advanced, enabling precise delivery to specific cell types.
  • Viral vectors like lentiviruses and adeno-associated viruses are key tools in gene therapy.

Purpose of the Study:

  • To engineer gene vectors for targeted cell entry using specific surface markers.
  • To explore applications in gene function studies and molecular medicine.

Main Methods:

  • Engineering viral vectors (lentiviruses, adeno-associated viruses) to display targeting ligands.
  • Utilizing cell surface markers for targeted vector binding and cell entry.
  • Demonstrating gene delivery to diverse cell types including endothelial cells, lymphocytes, tumor cells, and neural cells.

Main Results:

  • Vectors can be redirected to use chosen cell surface markers for entry.
  • Targeting ligands (peptides, single-chain antibodies, designed ankyrin repeat proteins) mediate specific binding.
  • Successful gene delivery demonstrated in various specialized cell types.

Conclusions:

  • Engineered gene vectors offer precise cell-type targeting for ex vivo and in vivo applications.
  • This technology enhances the potential for gene function studies and therapeutic interventions in molecular medicine.